REAX vs. NVO
Compare and contrast key facts about Real Brokerage Inc (REAX) and Novo Nordisk A/S (NVO).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: REAX or NVO.
Correlation
The correlation between REAX and NVO is 0.35, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
REAX vs. NVO - Performance Comparison
Loading data...
Key characteristics
REAX:
-0.27
NVO:
-1.13
REAX:
-0.20
NVO:
-1.63
REAX:
0.98
NVO:
0.79
REAX:
-0.48
NVO:
-0.80
REAX:
-0.80
NVO:
-1.43
REAX:
23.30%
NVO:
33.27%
REAX:
52.05%
NVO:
42.83%
REAX:
-74.76%
NVO:
-70.96%
REAX:
-38.29%
NVO:
-52.67%
Fundamentals
REAX:
$855.73M
NVO:
$307.00B
REAX:
-$0.07
NVO:
$3.53
REAX:
0.60
NVO:
1.01
REAX:
26.13
NVO:
14.53
REAX:
$1.42B
NVO:
$303.14B
REAX:
$127.58M
NVO:
$255.65B
REAX:
-$13.61M
NVO:
$154.08B
Returns By Period
In the year-to-date period, REAX achieves a -10.65% return, which is significantly higher than NVO's -19.47% return.
REAX
-10.65%
-11.80%
-21.26%
-14.20%
36.11%
N/A
N/A
NVO
-19.47%
13.79%
-32.51%
-48.12%
9.76%
17.94%
11.21%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
REAX vs. NVO — Risk-Adjusted Performance Rank
REAX
NVO
REAX vs. NVO - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Real Brokerage Inc (REAX) and Novo Nordisk A/S (NVO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
REAX vs. NVO - Dividend Comparison
REAX has not paid dividends to shareholders, while NVO's dividend yield for the trailing twelve months is around 2.37%.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
REAX Real Brokerage Inc | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
NVO Novo Nordisk A/S | 2.37% | 1.68% | 0.99% | 1.18% | 1.34% | 1.86% | 2.12% | 2.46% | 2.13% | 3.94% | 1.31% | 1.96% |
Drawdowns
REAX vs. NVO - Drawdown Comparison
The maximum REAX drawdown since its inception was -74.76%, which is greater than NVO's maximum drawdown of -70.96%. Use the drawdown chart below to compare losses from any high point for REAX and NVO. For additional features, visit the drawdowns tool.
Loading data...
Volatility
REAX vs. NVO - Volatility Comparison
The current volatility for Real Brokerage Inc (REAX) is 11.51%, while Novo Nordisk A/S (NVO) has a volatility of 12.47%. This indicates that REAX experiences smaller price fluctuations and is considered to be less risky than NVO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
REAX vs. NVO - Financials Comparison
This section allows you to compare key financial metrics between Real Brokerage Inc and Novo Nordisk A/S. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
REAX vs. NVO - Profitability Comparison
REAX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Real Brokerage Inc reported a gross profit of 33.94M and revenue of 353.98M. Therefore, the gross margin over that period was 9.6%.
NVO - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Novo Nordisk A/S reported a gross profit of 65.20B and revenue of 78.09B. Therefore, the gross margin over that period was 83.5%.
REAX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Real Brokerage Inc reported an operating income of -5.21M and revenue of 353.98M, resulting in an operating margin of -1.5%.
NVO - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Novo Nordisk A/S reported an operating income of 38.79B and revenue of 78.09B, resulting in an operating margin of 49.7%.
REAX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Real Brokerage Inc reported a net income of -4.97M and revenue of 353.98M, resulting in a net margin of -1.4%.
NVO - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Novo Nordisk A/S reported a net income of 29.03B and revenue of 78.09B, resulting in a net margin of 37.2%.